APA (7th ed.) Citation

Xu, B., Zhang, Q., Luo, Y., Tong, Z., Sun, T., Shan, C., . . . Li, T. Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial. Nature Portfolio.

Chicago Style (17th ed.) Citation

Xu, Binghe, et al. Lerociclib Plus Fulvestrant in Patients with HR+/HER2− Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy: LEONARDA-1 a Phase III Randomized Trial. Nature Portfolio.

MLA (9th ed.) Citation

Xu, Binghe, et al. Lerociclib Plus Fulvestrant in Patients with HR+/HER2− Locally Advanced or Metastatic Breast Cancer Who Have Progressed on Prior Endocrine Therapy: LEONARDA-1 a Phase III Randomized Trial. Nature Portfolio.